Publication | Open Access

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial

Gastrointestinal OncologyMedicineClinical TrialsColorectal CancerMetastatic Colorectal CancerImmune Checkpoint InhibitorFirst-line TreatmentPharmacotherapyCancer TreatmentOncologyRadiation OncologyFinal ResultsHealth Sciences